Profile of anti-IL-5 mAb mepolizumab in the treatment of severe refractory asthma and hypereosinophilic diseases

Profile of anti-IL-5 mAb mepolizumab in the treatment of severe refractory asthma and hypereosinophilic diseases

Francesco Menzella,1 Mirco Lusuardi,2 Carla Galeone,1 Sofia Taddei,1 Luigi Zucchi1 1Department of Cardiac-Thoracic-Vascular and Intensive Care Medicine, Pneumology Unit, Istituto di Ricovero e Cura a Carattere Scientifico- Arcispedale Santa Maria Nuova, Reggio Emilia, Italy; 2Unit of Respiratory Reh...

Full description

Bibliographic Details
Main Authors: Menzella F, Lusuardi M, Galeone C, Taddei S, Zucchi L
Format: Article
Language:English
Published: Dove Medical Press 2015-10-01
Series:Journal of Asthma and Allergy
Online Access:https://www.dovepress.com/profile-of-anti-il-5-mab-mepolizumab-in-the-treatment-of-severe-refrac-peer-reviewed-article-JAA

Internet

https://www.dovepress.com/profile-of-anti-il-5-mab-mepolizumab-in-the-treatment-of-severe-refrac-peer-reviewed-article-JAA

Similar Items